CVS Health (CVS) Stock Price

CVS Health Price

NYSE·CLOSED
105.08USD-2.85 (-2.68 %)
Market closed

Over the last 19 years CVS Health grew revenue by 12.4% annually, reaching 402.07 B USD. Earnings per share have declined at 0.8% per year over the last 19 years. For CVS Health, the net margin of 0.4% is down versus 2.7% a few years ago. At today's price the dividend yield works out to roughly 2.53%. The payout ratio is around 192% of earnings. The dividend has grown at 16.1% per year over the past 19 years. The consensus 12-month price target for CVS Health is 96.90 USD, about 7.8% below where the stock trades today. Of 33 analysts, 26 rate the stock a buy — an overall Buy consensus. The stock trades about 71% above its 52-week low.

CVS Health stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of CVS Health over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how CVS Health stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing CVS Health's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

CVS Health Stock Price History
DateCVS Health Price
7/31/2026105.08 USD
7/29/2026107.93 USD
7/27/2026106.83 USD
7/23/2026106.89 USD
7/22/2026108.08 USD
7/21/2026110.60 USD
7/20/2026107.61 USD
7/17/2026107.47 USD
7/16/2026106.50 USD
7/15/2026105.91 USD
7/14/2026106.18 USD
7/13/2026105.92 USD
7/10/2026104.15 USD
7/9/2026102.81 USD
7/8/2026104.35 USD
7/7/2026104.33 USD
7/6/2026102.83 USD
7/2/2026104.72 USD
7/1/2026104.81 USD
6/30/2026103.45 USD
6/29/2026104.24 USD
6/26/2026104.34 USD
6/25/2026104.66 USD
6/24/2026101.87 USD
6/23/2026101.57 USD
6/22/2026102.47 USD
6/18/202698.37 USD
6/17/2026100.00 USD
6/16/202699.82 USD
6/15/2026100.21 USD
6/12/2026102.54 USD
6/11/202699.08 USD
6/10/202697.24 USD
6/9/202697.06 USD
6/8/202697.08 USD
6/5/202696.20 USD
6/4/202694.19 USD
6/3/202690.89 USD
6/2/202690.71 USD
6/1/202690.75 USD
5/29/202691.35 USD
5/28/202693.54 USD
5/27/202691.63 USD
5/26/202691.63 USD
5/22/202693.40 USD
5/21/202693.46 USD
5/20/202694.65 USD
5/19/202694.18 USD
5/18/202695.99 USD
5/15/202695.89 USD
5/14/202697.15 USD
5/13/202698.11 USD
5/12/202695.15 USD
5/11/202692.22 USD
5/8/202690.55 USD
5/7/202687.36 USD
5/6/202686.86 USD
5/5/202680.69 USD
5/4/202682.01 USD
5/1/202682.09 USD
4/30/202683.29 USD
4/29/202683.90 USD
4/28/202680.98 USD
4/27/202678.36 USD
4/24/202677.94 USD
4/23/202678.86 USD
4/22/202676.43 USD
4/21/202677.36 USD
4/20/202676.58 USD
4/17/202677.30 USD
4/16/202676.79 USD
4/15/202674.99 USD
4/14/202677.62 USD
4/13/202678.09 USD
4/10/202679.33 USD
4/9/202678.84 USD
4/8/202678.79 USD
4/7/202678.22 USD
4/6/202678.92 USD
4/2/202673.70 USD
4/1/202672.49 USD
3/31/202671.82 USD
3/30/202670.14 USD
3/27/202670.09 USD
3/26/202671.27 USD
3/25/202672.18 USD
3/24/202673.12 USD
3/23/202671.14 USD
3/20/202671.98 USD
3/19/202672.16 USD
3/18/202671.86 USD
3/17/202674.79 USD
3/16/202675.85 USD
3/13/202676.27 USD
3/12/202676.49 USD
3/11/202675.54 USD
3/10/202676.48 USD
3/9/202678.26 USD
3/6/202677.82 USD
3/5/202678.69 USD
3/4/202680.57 USD
3/3/202680.49 USD
3/2/202681.66 USD
2/27/202679.90 USD
2/26/202678.03 USD
2/25/202676.19 USD
2/24/202674.18 USD
2/23/202676.94 USD
2/20/202676.68 USD
2/19/202677.38 USD
2/18/202677.75 USD
2/17/202677.97 USD
2/13/202678.52 USD
2/12/202677.93 USD
2/11/202677.02 USD
2/10/202675.70 USD
2/9/202675.86 USD
2/6/202678.02 USD
2/5/202675.72 USD
2/4/202675.26 USD
2/3/202676.83 USD
2/2/202675.25 USD
1/30/202674.51 USD
1/29/202674.23 USD
1/28/202673.88 USD
1/27/202672.28 USD
1/26/202674.59 USD
1/23/202683.01 USD
1/22/202682.70 USD
1/21/202681.45 USD
1/20/202680.12 USD
1/16/202678.72 USD
1/15/202681.32 USD
1/14/202679.33 USD
1/13/202680.68 USD
1/12/202680.36 USD
1/9/202680.30 USD
1/8/202680.89 USD
1/7/202679.79 USD
1/6/202680.50 USD
1/5/202680.32 USD
1/2/202680.57 USD
12/31/202579.36 USD
12/30/202579.88 USD
12/29/202580.02 USD
12/26/202579.61 USD
12/24/202579.12 USD
12/23/202578.04 USD
12/22/202578.36 USD
12/19/202577.82 USD
12/18/202577.79 USD
12/17/202577.88 USD
12/16/202578.29 USD
12/15/202579.69 USD
12/12/202579.04 USD
12/11/202580.83 USD
12/10/202579.02 USD
12/9/202578.35 USD
12/8/202576.50 USD
12/5/202575.63 USD
12/4/202576.75 USD
12/3/202575.00 USD
12/2/202577.62 USD
12/1/202579.22 USD
11/28/202580.36 USD
11/26/202579.86 USD
11/25/202578.47 USD
11/24/202577.90 USD
11/21/202578.05 USD
11/20/202576.04 USD
11/19/202576.36 USD
11/18/202577.94 USD
11/17/202578.41 USD
11/14/202578.01 USD
11/13/202579.24 USD
11/12/202580.26 USD
11/11/202579.99 USD
11/10/202577.54 USD
11/7/202578.99 USD
11/6/202578.66 USD
11/5/202578.55 USD
11/4/202577.81 USD
11/3/202578.44 USD
10/31/202578.16 USD
10/30/202577.01 USD
10/29/202580.42 USD
10/28/202582.66 USD
10/27/202582.52 USD
10/24/202581.94 USD
10/23/202581.42 USD
10/22/202581.74 USD
10/21/202583.07 USD
10/20/202582.48 USD
10/17/202582.90 USD
10/16/202581.52 USD
10/15/202580.67 USD
10/14/202579.66 USD
10/13/202577.72 USD
10/10/202577.87 USD
10/9/202578.01 USD
10/8/202576.95 USD
10/7/202577.12 USD
10/6/202576.62 USD
10/3/202577.41 USD
10/2/202577.45 USD
10/1/202576.87 USD
9/30/202575.39 USD
9/29/202575.57 USD
9/28/202575.57 USD
9/25/202575.77 USD
9/24/202574.61 USD
9/23/202576.50 USD
9/22/202575.15 USD
9/19/202574.80 USD
9/18/202573.97 USD
9/17/202574.00 USD
9/16/202573.48 USD
9/15/202573.23 USD
9/12/202574.93 USD
9/11/202574.40 USD
9/10/202573.97 USD
9/9/202571.75 USD
9/8/202570.22 USD
9/5/202573.80 USD
9/4/202573.63 USD
9/3/202573.32 USD
9/2/202574.12 USD
8/29/202572.60 USD
8/28/202572.14 USD
8/27/202571.93 USD
8/26/202571.57 USD
8/25/202571.21 USD
8/22/202571.31 USD
8/21/202571.45 USD
8/20/202570.89 USD
8/19/202570.97 USD
8/18/202570.17 USD
8/15/202568.58 USD
8/14/202568.02 USD
8/13/202565.92 USD
8/12/202565.51 USD
8/11/202564.88 USD
8/8/202565.50 USD
8/7/202563.58 USD
8/6/202563.51 USD
8/5/202563.33 USD
8/4/202561.56 USD
7/31/202562.47 USD
Access this data via the Eulerpool API
Get Free API Key

CVS Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
357.78 B USD
13.74 B USD
8.34 B USD
Jan 1, 2024
372.81 B USD
8.52 B USD
4.61 B USD
Jan 1, 2025
402.07 B USD
5.26 B USD
1.77 B USD
Jan 1, 2026 (e)
409.04 B USD
11.94 B USD
9.47 B USD
Jan 1, 2027 (e)
426.28 B USD
12.44 B USD
10.72 B USD
Jan 1, 2028 (e)
448.97 B USD
13.10 B USD
12.31 B USD
Jan 1, 2029 (e)
477.38 B USD
13.93 B USD
13.92 B USD
Jan 1, 2030 (e)
498.69 B USD
14.55 B USD
15.50 B USD

CVS Health Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 31, 2026, 5:15 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
DIV.USD
DIV. GROWTH%
SHARESB
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
153.29177.55184.79194.58256.78268.71292.11322.47357.78372.81402.07409.04426.28448.97477.38498.69
9.9915.824.085.3031.964.658.7110.3910.954.207.851.744.215.326.334.47
17.3116.2415.4416.2117.7318.2517.8416.9015.2113.7913.7713.7713.7713.7713.7713.77
26.5328.8328.5331.5445.5349.0552.1254.5054.4351.4055.3656.3258.7061.8265.7368.67
9.489.729.544.0212.0312.6813.317.9513.748.525.2611.9412.4413.1013.9314.55
6.185.475.162.074.694.724.562.473.842.281.312.922.922.922.922.92
5.245.326.62-0.596.637.188.004.318.344.611.779.4710.7212.3113.9215.50
12.771.5324.54-108.97-1,216.848.2211.45-46.1293.55-44.70-61.68435.5213.2014.8513.0511.38
1.401.702.002.002.002.002.002.202.422.662.662.662.822.98––
1.4521.4317.65––––10.0010.009.92––6.025.67––
1.111.071.021.121.311.321.341.321.291.261.281.281.281.281.281.28
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales CVS Health generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue CVS Health retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare CVS Health's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares CVS Health has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against CVS Health's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

CVS Health stock margins

The CVS Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CVS Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CVS Health.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
17.84 %
4.56 %
2.74 %
Jan 1, 2022
16.90 %
2.47 %
1.34 %
Jan 1, 2023
15.21 %
3.84 %
2.33 %
Jan 1, 2024
13.79 %
2.28 %
1.24 %
Jan 1, 2025
13.77 %
1.31 %
0.44 %
Jan 1, 2026 (e)
13.77 %
2.92 %
2.31 %
Jan 1, 2027 (e)
13.77 %
2.92 %
2.51 %
Jan 1, 2028 (e)
13.77 %
2.92 %
2.74 %

CVS Health Stock Revenue, EBIT, Earnings per Share

The CVS Health earnings per share therefore indicates how much revenue CVS Health has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
218.65 USD
9.96 USD
5.99 USD
Jan 1, 2022
244.48 USD
6.03 USD
3.27 USD
Jan 1, 2023
276.70 USD
10.63 USD
6.45 USD
Jan 1, 2024
295.65 USD
6.75 USD
3.66 USD
Jan 1, 2025
314.85 USD
4.12 USD
1.38 USD
Jan 1, 2026 (e)
321.83 USD
9.35 USD
7.45 USD
Jan 1, 2027 (e)
335.39 USD
9.74 USD
8.43 USD
Jan 1, 2028 (e)
353.24 USD
10.26 USD
9.69 USD

CVS Health business model & stock analysis

CVS Health Corp is an American company operating in the healthcare sector. It was founded in 1963 as Consumer Value Stores and is headquartered in Woonsocket, Rhode Island. The company has experienced significant expansion since its founding and is now one of the largest pharmacy chains in the USA. It operates more than 10,000 stores in the USA and has also expanded internationally in recent years. The business model of CVS Health Corp is based on various divisions under one roof. The core division of the company is the CVS Pharmacy chain, which offers a wide range of prescription and over-the-counter medications. The company focuses on a broad customer base and operates pharmacies in cities, suburbs, and rural areas. Additionally, the company places a special emphasis on developing innovative products and services to improve the well-being of its customers. In addition to the pharmacy chain, CVS Health Corp also operates the CVS Caremark division, which specializes in providing medications for businesses. The company offers special programs to improve access to medications for employees and reduce costs for businesses. The division also offers consultation to improve employee healthcare and lower healthcare costs. Other divisions of CVS Health Corp include MinuteClinic and Long-Term Care Pharmacy. MinuteClinic is an outpatient medical facility found in many CVS pharmacies. Here, customers can receive medical advice and treatment without having to endure long wait times. Long-Term Care Pharmacy provides specialized care services for patients in long-term care facilities and ensures that prescribed medications are administered effectively and safely. To expand its offerings for customers, CVS Health Corp also provides online services. Through the company's website, customers can order medications, manage their prescriptions, and receive information on various health topics. By utilizing technology, CVS Health Corp aims to provide its customers with even better healthcare and simplify the medical treatment process. CVS Health Corp also takes a leading role in environmental protection. The company has set a goal to reduce its CO2 emissions by 50% by the year 2020. Additionally, the company has developed a medication disposal program to reduce waste and minimize the environmental harm caused by medications. Overall, CVS Health Corp has undergone impressive development in recent years. With its wide range of products and innovative services, the company has established itself as a major player in the healthcare industry. And by focusing on sustainability and environmental protection, it demonstrates its commitment to social responsibility.

CVS Health SWOT Analysis

Strengths

CVS Health Corp possesses a vast network of retail stores, pharmacies, and healthcare clinics across the United States. This wide market presence enables the company to reach a large customer base, establishing itself as a leading provider of pharmacy services and healthcare products.

CVS Health Corp has built a strong brand reputation through its commitment to quality healthcare services, convenient store locations, and a diverse range of products. This has resulted in a loyal customer base that trusts the CVS brand for their healthcare needs.

In addition to its pharmacies, CVS Health Corp also operates health insurance plans, provides pharmacy benefit management services, and offers specialty pharmacy services. This diversity in revenue streams helps the company mitigate risks and adapt to changing market conditions.

Weaknesses

A significant portion of CVS Health Corp's revenue comes from prescription drug sales. This reliance on a single product category exposes the company to risks such as regulatory changes, pricing pressures, and increased competition in the pharmaceutical industry.

While CVS Health Corp has a strong domestic presence, its international operations are relatively limited. This lack of global exposure reduces opportunities for expansion and leaves the company vulnerable to economic fluctuations within the United States.

Opportunities

The increasing population, aging demographics, and advancements in medical technology contribute to the growing demand for healthcare services. CVS Health Corp can leverage this opportunity by expanding its healthcare offerings and investing in innovative solutions.

The rise of telehealth and digital solutions presents an opportunity for CVS Health Corp to enhance its healthcare service delivery. By investing in technology and providing convenient virtual healthcare options, the company can tap into a new market segment and improve customer experience.

Threats

CVS Health Corp faces intense competition from other retail pharmacy chains, online pharmacies, and pharmacy benefits managers. This competition can lead to pricing pressures, margin erosion, and the potential loss of market share.

The healthcare industry is subject to stringent regulations and reimbursement policies. Changes in government regulations or reimbursement rates can significantly impact CVS Health Corp's profitability and operations.

CVS Health Segments

CVS Health Revenue by Segment (1/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Products
Premiums
Services
Jan 1, 2010
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD

CVS Health Revenue by Segment (2/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Pharmacy
Front Store
Other
Jan 1, 2010
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD

CVS Health Revenue by Segment (3/6)

  • 3 Years

  • 5 Years

  • Max

Corporate/ Other
Details
Date
Corporate/ Other
Jan 1, 2010
0.00 USD
Jan 1, 2014
0.00 USD
Jan 1, 2019
512.00 M USD

CVS Health Revenue by Segment (4/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Pharmacy Services Segment
Retail Pharmacy Segment
Corporate Segment
Details
Date
Pharmacy Services Segment
Retail Pharmacy Segment
Corporate Segment
Jan 1, 2010
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2014
88.44 B USD
67.80 B USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD

CVS Health Revenue by Segment (5/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Intersegment Eliminations
Details
Date
Intersegment Eliminations
Jan 1, 2010
0.00 USD
Jan 1, 2014
-16.87 B USD
Jan 1, 2019
0.00 USD

CVS Health Revenue by Segment (6/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Details
Date
Pharmacy Services Segment
Retail Pharmacy Segment
Intersegment Eliminations
Jan 1, 2010
47.78 B USD
57.35 B USD
-8.71 B USD
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD

CVS Health Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

CVS Health historical P/E ratio, EBIT multiple, and P/S ratio

CVS Health annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

CVS Health shares outstanding

The number of shares of CVS Health was 1.28 B in 2025. This indicates how many shares CVS Health is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
1.34 B Stocks
Jan 1, 2022
1.32 B Stocks
Jan 1, 2023
1.29 B Stocks
Jan 1, 2024
1.26 B Stocks
Jan 1, 2025
1.28 B Stocks
Jan 1, 2026 (e)
1.28 B Stocks
Jan 1, 2027 (e)
1.28 B Stocks
Jan 1, 2028 (e)
1.28 B Stocks

CVS Health stock splits

In CVS Health's history, there have been no stock splits.

CVS Health Dividend History

37 years of dividend payments

YearAnnual DividendYoY ChangePayments
20261.33USDYTD—2×
Jan 22, 20260.67USD 0.0%1/2
Apr 23, 20260.67USD 0.0%2/2
20252.66USD 0.0%4×
Jan 23, 20250.67USD 0.0%1/4
Apr 22, 20250.67USD 0.0%2/4
Jul 22, 20250.67USD 0.0%3/4
Oct 23, 20250.67USD 0.0%4/4
20242.66USD↑ 9.9%4×
20232.42USD↑ 10.0%4×
20222.20USD↑ 10.0%4×
20212.00USD 0.0%4×
20202.00USD 0.0%4×
20192.00USD 0.0%4×
20182.00USD 0.0%4×
20172.00USD↑ 17.6%4×

CVS Health dividend history and estimates

In 2025, CVS Health paid a dividend amounting to 2.66 USD. Dividend means that CVS Health distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
2.00 USD
0.00 USD
Jan 1, 2022
2.20 USD
0.00 USD
Jan 1, 2023
2.42 USD
0.00 USD
Jan 1, 2024 (e)
2.66 USD
0.00 USD
Jan 1, 2025
2.66 USD
0.00 USD
Jan 1, 2026 (e)
1.33 USD
1.33 USD
Jan 1, 2027 (e)
0.00 USD
2.82 USD
Jan 1, 2028 (e)
0.00 USD
2.98 USD

CVS Health dividend payout ratio

In 2025, CVS Health had a payout ratio of 192.13%. The payout ratio indicates the percentage of the company's profits that CVS Health distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
33.40 %
Jan 1, 2022
67.31 %
Jan 1, 2023
37.50 %
Jan 1, 2024
72.70 %
Jan 1, 2025
192.13 %
Jan 1, 2026 (e)
35.71 %
Jan 1, 2027 (e)
33.39 %
Jan 1, 2028 (e)
30.78 %

Current CVS Health forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy78.79 % (26)
Hold21.21 % (7)
Sell0.00 % (0)
12M Price Target
96.90
Last Price
107.93
Currency
USD
12M Return Potential
-10.22 %
LTM Return
0 %

CVS Health Earnings Calls

2024
2023

CVS Health Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
8/5/20261.85USD101.10 BUSD2026 Q2
5/6/20262.23USD96.15 BUSD2026 Q1
2/11/20261.00USD104.63 BUSD2025 Q4
2/10/20261.00USD104.66 BUSD2025 Q4
5/1/20242.05USD84.77 BUSD2024 Q1
2/6/20241.98USD90.94 BUSD2023 Q4
8/1/20232.43USD83.51 BUSD2023 Q2
5/2/20232.24USD80.41 BUSD2023 Q1
2/7/20231.94USD77.59 BUSD2022 Q4
11/2/20222.01USD77.90 BUSD2022 Q3
...

EESG©

Eulerpool ESG Scorecard© for the CVS Health stock

73/100
87
Environment
86
Social
45
Governance
E

Environment

20
Scope 1 - Direct Emissions261,522
Scope 2 - Indirect emissions from purchased energy653,702
Scope 3 - Indirect emissions within the value chain11,387,115
Total CO₂ emissions915,224
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides—
Palm Oil
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees70
Percentage of women in management—
Percentage of Asian employees12
Share of Asian management14
Percentage of Hispanic/Latino employees17
Hispano/Latino Management share9
Percentage of Black employees18
Black Management Share11
Percentage of white employees46
White Management Share62
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

CVS Health Executives and Management Board

JJ

Mr. J. David Joyner

(61)

Chair of the Board, President, Chief Executive Officer · since 2011

Compensation17.81 M USD
PS

Mr. Prem Shah

(45)

Executive Vice President, Group President

Compensation13.27 M USD
SK

Mr. Samrat Khichi

(57)

Executive Vice President, Chief Policy Officer and General Counsel

Compensation11.89 M USD
TM

Mr. Tilak Mandadi

(61)

Executive Vice President, Chief Data, Digital, Analytics and Technology Officer

Compensation11.36 M USD
HC

Ms. Heidi Capozzi

(55)

Chief People Officer and Executive Vice President

Compensation6.85 M USD

CVS Health Supply Chain

CVS Health Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
30 companies
#Name1M3M6M1Y2YTrend
1
CRA
Supplier
0.35
0.76
0.64
0.92
0.92
2
Golden Entertainment
Supplier
-0.34
0.12
0.75
0.91
0.90
3
Tenet Healthcare Corporation
Supplier
0.64
0.68
0.75
0.92
0.90
4
Anthem
0.55
-0.52
0.51
0.87
0.88
5
Omnicell
Supplier
0.42
0.50
0.31
0.88
0.83
#Name1M3M6M1Y2YTrend
1
Harmony Biosciences Holdings
Supplier
0.34
0.73
0.44
-0.55
—
2
Pulmonx
Supplier
0.77
-0.16
-0.50
-0.45
—
3
Everbridge
Supplier
0.75
0.68
-0.02
—
—
4
Nongshim Co., Ltd.
Supplier
0.12
-0.65
0.27
0.34
-0.17
5
ANI Pharma
Supplier
0.61
-0.64
-0.13
0.56
0.03

Frequently asked questions about CVS Health

The business model of CVS Health Corp revolves around being a healthcare company with a retail presence. CVS Health Corp operates a network of retail pharmacies, providing prescription drugs, over-the-counter medications, and health products to consumers. They also offer various healthcare services, including walk-in clinics, telehealth consultations, and wellness programs. In addition, CVS Health Corp provides pharmacy benefit management services, partnering with employers and insurance companies to manage drug costs and improve health outcomes for their members. With their extensive reach in both the retail and healthcare sectors, CVS Health Corp aims to provide customers with convenient access to healthcare products and services, ultimately improving overall health and well-being.

All fundamentals and in-depth analysis of CVS Health

Our stock analysis for CVS Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CVS Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

CVS Health Stock
CVS Health Revenue→
CVS Health Stock
CVS Health Net Income→
CVS Health Stock
CVS Health P/E→
CVS Health Stock
CVS Health P/S→
CVS Health Stock
CVS Health EBIT→
CVS Health Stock
CVS Health Dividend→
CVS Health Stock
CVS Health Directors Dealings→
CVS Health Stock
CVS Health Stocks→
CVS Health Stock
CVS Health Market capitalization→
CVS Health Stock
CVS Health Debt→
CVS Health Stock
CVS Health Liabilities→
CVS Health Stock
CVS Health Equity→
CVS Health Stock
CVS Health AAQS→
CVS Health Stock
CVS Health Employees→
CVS Health Stock
CVS Health ROE→
CVS Health Stock
CVS Health ROA→
CVS Health Stock
CVS Health ROCE→
CVS Health Stock
CVS Health News→
CVS Health Stock
CVS Health Analyst Price Targets→

Health Stocks

CyberdyneCVS GroupCybinCVRxCyclerion TherapeuticsCVC TechnologiesCyclopharmCuu Long Pharmaceutical JSCCyfuse Biomedical KKCutia TherapeuticsCynata TherapeuticsCurocellAll Stocks A–Z →